Tech Company Financing Transactions
OptiScan Biomedical Funding Round
OptiScan Biomedical, based in Hayward, secured $20 million from private investors.
Transaction Overview
Company Name
Announced On
3/21/2019
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series E
Investors
Proceeds Purpose
Use of the proceeds from the financing will support the commercialization of the company's lead product, the OptiScanner 5000, in the United States. OptiScan will also use a portion of the funding to continue the expansion of the company's OptiScanner platform to monitor additional analytes of interest for critically ill patients.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
24590 Clawiter Rd.
Hayward, CA 94545
USA
Hayward, CA 94545
USA
Phone
Website
Email Address
Overview
OptiScan Biomedical Corporation has developed an innovative monitoring platform for use in hospital intensive care units (ICU) to support clinicians in detecting changes more rapidly in critically ill patients, enabling more timely intervention.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Cary Vance
Chief Financial Officer
Patrick Nugent
VP - Operations
Mario Cervantes
VP - R & D
Jim Causey
VP - Regulatory Affairs
Chip Zimliki
Browse more venture capital transactions:
Prev: 3/21/2019: NS8 venture capital transaction
Next: 3/21/2019: Skedulo venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs